Sagent Recalls Fluconazole Injection Due to Cross-Contamination with Metronidazole
Sagent Pharmaceuticals is recalling specific lots of Fluconazole Injection due to cross-contamination with metronidazole. The affected product is distributed nationwide and in Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls are assigned a severity score of 4 (Severe), particularly when involving potential adverse health consequences from contamination.
Plain-English summary
Sagent Pharmaceuticals Inc is recalling 37,450 bags of Fluconazole Injection, USP (in 0.9% Sodium Chloride), 200 mg per 100 ml, Single-Dose Container Bag. The recall is being conducted because of cross-contamination with metronidazole. The affected product is identified by Lot # 40608 and has an expiration date of 5/17.
The recalled product was distributed nationwide and in Puerto Rico. The agency has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Healthcare providers and patients should stop using the affected lots of Fluconazole Injection and contact Sagent Pharmaceuticals or their local FDA office for further instructions on how to return or dispose of the product.
The recalled product
- Product
- Fluconazole Injection, USP (in 0.9% Sodium Chloride), 200 mg per 100 ml, Single-Dose Container Bag, Rx only, Mfd. for SAGENT Pharmaceuticals, Schaumburg, IL 60195, NDC 25021-0113-82
- Manufacturer
- Sagent Pharmaceuticals Inc
- Category
- Drug — Antifungal Injection
- Affected units
- 37,450
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 40608
- Exp 5/17
Distribution
Related recalls
Same manufacturer · Sagent Pharmaceuticals Inc
See all →- HighNafcillin Injectable Medication Recalled for Sterility Assurance Failure
FDA (Drugs) · 2023-05-31
- HighNafcillin for Injection recalled nationwide for lack of sterility assurance
FDA (Drugs) · 2023-05-31
- HighNafcillin for Injection Recalled Nationwide for Lack of Sterility Assurance
FDA (Drugs) · 2023-05-31
- ModerateHeparin Sodium Injection Recalled Due to Labeling Issue
FDA (Drugs) · 2023-03-15
- SevereSagent Recalls Phenylephrine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2021-03-24
Same hazard · cross contamination
See all →- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
- ModeratePrimidone tablets recalled over potential acemetacin cross-contamination at API manufacturer
FDA (Drugs) · 2026-06-17
- HighFly By Jing creamy sesame noodles may contain undeclared peanut
FDA (Food) · 2026-06-03
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27